142 related articles for article (PubMed ID: 11036962)
21. UFT in the treatment of colorectal and breast cancer.
Sun W; Haller D
Oncology (Williston Park); 2001 Jan; 15(1 Suppl 2):49-56. PubMed ID: 11219978
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
23. [Experimental study on combination chemotherapy of UFT and calcium antagonist in gastric cancer].
Nakano GI; Katoh H; Ikeda H; Sakamoto K; Nagamachi Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):793-8. PubMed ID: 2496667
[TBL] [Abstract][Full Text] [Related]
24. Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.
Okabe H; Toko T; Saito H; Nakano K; Fujioka A; Yuasa C; Takeda S; Unemi N
Anticancer Res; 1997; 17(1A):157-64. PubMed ID: 9066646
[TBL] [Abstract][Full Text] [Related]
25. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer.
Gyldenkerne N; Glimelius B; Frödin JE; Kjaer M; Pfeiffer P; Hansen F; Keldsen N; Sandberg E; Jakobsen A
Acta Oncol; 2004; 43(3):276-9. PubMed ID: 15244251
[TBL] [Abstract][Full Text] [Related]
27. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
[TBL] [Abstract][Full Text] [Related]
28. Retrospectively comparative evaluation of the first- and second-line chemotherapy with campto and oxaliplatin combined with oral tegafur/uracil (UFT)/leucovorin (LV) in patients with metastatic colorectal cancer.
Hsiao SC; Lin JF; Chuang MT; Lee YA; Wu DL
Int Surg; 2009; 94(4):298-303. PubMed ID: 20302025
[TBL] [Abstract][Full Text] [Related]
29. UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer.
Alliot C
Br J Cancer; 2004 Aug; 91(3):599-600; author reply 599-601. PubMed ID: 15238988
[No Abstract] [Full Text] [Related]
30. Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.
Raymond E; Louvet C; Tournigand C; Coudray AM; Faivre S; De Gramont A; Gespach C
Int J Oncol; 2002 Aug; 21(2):361-7. PubMed ID: 12118332
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant effects of calmodulin antagonists on antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil (ftorafur) and a mixture of ftorafur and uracil (UFT) in nude mice bearing human ovarian carcinomas.
Kikuchi Y; Oomori K; Iwano I; Kizawa I; Miyauchi M; Kita T; Kuki E
Gynecol Oncol; 1989 Nov; 35(2):172-6. PubMed ID: 2509301
[TBL] [Abstract][Full Text] [Related]
32. The role of new agents in the treatment of colorectal cancer.
Folprecht G; Köhne CH
Oncology; 2004; 66(1):1-17. PubMed ID: 15031593
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
Shirasaka T; Nakano K; Takechi T; Satake H; Uchida J; Fujioka A; Saito H; Okabe H; Oyama K; Takeda S; Unemi N; Fukushima M
Cancer Res; 1996 Jun; 56(11):2602-6. PubMed ID: 8653704
[TBL] [Abstract][Full Text] [Related]
34. Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer.
Kim K; Nam E; Lee NS; Lee HR; Lee JY; Lee HR; Park SH; Oh SY; Kim JH; Song SY; Park JO; Kim WS; Jung CW; Im YH; Lee MH; Lee WY; Chun H; Park CH; Park K; Kang WK
Am J Clin Oncol; 2002 Aug; 25(4):354-7. PubMed ID: 12151964
[TBL] [Abstract][Full Text] [Related]
35. UFT in combination with oxaliplatin: clinical phase I study in patients with advanced or metastatic solid tumors.
Sastre J; Aranda E; Abad A; Gallego J; Manzano JL; Gómez A; Carrato A; López E; Díaz-Rubio E;
Anticancer Drugs; 2006 Apr; 17(4):417-21. PubMed ID: 16549999
[TBL] [Abstract][Full Text] [Related]
36. UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysis.
Vormittag L; Kornek GV; Gruhsmann B; Lenauer A; Föger A; Depisch D; Lang F; Scheithauer W
Anticancer Drugs; 2007 Jul; 18(6):709-12. PubMed ID: 17762401
[TBL] [Abstract][Full Text] [Related]
37. Mitomycin C and UFT/leucovorin as salvage treatment in patients with advanced colorectal cancer.
Michalaki V; Gennatas S; Gennatas C
J BUON; 2010; 15(2):270-3. PubMed ID: 20658720
[TBL] [Abstract][Full Text] [Related]
38. [Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues].
Yoshiya N; Adachi S; Misawa Y; Ishida M; Yuzawa H; Kanazawa K; Takeuchi S
Gan To Kagaku Ryoho; 1988 Feb; 15(2):285-9. PubMed ID: 3124768
[TBL] [Abstract][Full Text] [Related]
39. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Douillard JY; Hoff PM; Skillings JR; Eisenberg P; Davidson N; Harper P; Vincent MD; Lembersky BC; Thompson S; Maniero A; Benner SE
J Clin Oncol; 2002 Sep; 20(17):3605-16. PubMed ID: 12202661
[TBL] [Abstract][Full Text] [Related]
40. [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--growth-inhibitory activity of combination against human tumor xenograft].
Saito H; Okabe H; Nakano K; Fujioka A; Toko T; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1995 Nov; 22(13):1919-25. PubMed ID: 7487121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
